Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.
about
Adoptive T cell therapy for cancer in the clinicChimeric Antigen Receptors Modified T-Cells for Cancer Therapy90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrChimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall StreetThe impact of the myeloid response to radiation therapyFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsCurrent Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Understanding high endothelial venules: Lessons for cancer immunologyRadiation meets immunotherapy - a perfect match in the era of combination therapy?Defects in the acquisition of tumor-killing capability of CD8+ cytotoxic T cells in streptozotocin-induced diabetic miceOvercoming tumor immune evasion with an unique arbovirusControl of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response.Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma modelCCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsThe intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance.A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer.Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.Redirecting the immune response: role of adoptive T cell therapy.Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.Relationship between RGS5 expression and differentiation and angiogenesis of gastric carcinomaClinical application of genetically modified T cells in cancer therapy.Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses.A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment.Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation.CD4 cells can be more efficient at tumor rejection than CD8 cellsNOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth DelayTumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitorsRadiation, inflammation, and immune responses in cancerA rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development.Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer.Role of T lymphocytes in tumor response to radiotherapy.
P2860
Q24680405-C7F98388-BA28-4DE3-9406-B65BFD60112FQ26773309-7538EA34-104D-407B-AF98-741B90CE85D8Q26776480-73D13385-7C55-4BD0-AD29-9F6B01CFCE76Q26799357-3E9D4D7B-F8A2-4098-A9DC-39195160239EQ26851643-77D118F9-4035-4D04-9C95-E59894360F59Q26865532-E794F58A-3B33-460F-9593-7D434B32751CQ27002209-C4F1041F-13F2-413A-8956-E9537E9FCF13Q27005794-5089E05F-461D-4776-B02D-A7F87A9AA6C8Q27005913-085B81D2-663D-465B-86AA-7A3B69E0107DQ27335802-FAD3FA1F-87C7-4B0B-AE14-33F606CECE61Q28081774-2E9DF7D5-5730-4C93-80D2-63E27B6B31D2Q29994573-1E653906-11A3-4360-8787-B6020C436397Q33221445-38469EE9-38CF-4DE6-A1B8-DA0ED3C0D5BDQ33614807-C471E68F-3267-4A28-921C-12E11C2D740BQ33726546-3851ACDC-DA53-4BC4-9CA9-ACF5B4AF96AEQ33730171-D689E673-A59E-435C-9318-A2B8C819138AQ33746544-2E28A3C8-FFAC-466D-8BF0-4116B481BE8EQ34036020-96367A29-E300-473C-847B-807FBC879C4DQ34065630-34C41BC5-5793-4DC6-8753-9A8106D7FFC6Q34123238-D8DDC4E8-368B-476C-B59B-11C9C92E16FBQ34278609-BEF97354-D99C-47FD-A8B1-8F61FD6C07F7Q34326006-EAE623BF-F1E5-4C4F-B4CC-5E76A871BC98Q34354756-EDFDBE10-30E6-4AB8-8751-08B44E7F640DQ34511646-1ED3F60B-1117-43B9-BBCC-C21A7BB89F1EQ34560857-2DC6F361-3D12-416C-A824-A5D5689A33A9Q34667021-99654160-8A86-4FBD-A485-6209B1CDA935Q34682173-5EB7E5F4-1E1F-4D4C-8227-3E9B862D7275Q35012602-EEAA5852-94C4-42FF-AAA6-C1AAA7D1567BQ35369944-82611678-0E17-4DAF-80D4-46E8AC8586E0Q35540109-BADBC67D-CC5D-47FE-B904-D3821A704DFDQ35670632-73517E2E-E414-415C-9C41-6D6DD827066BQ35752201-51C7FAF4-6496-42E2-BDC0-891609B975BEQ35839925-EA4B735B-1594-4A64-BA1D-EB53961F29D0Q35862690-76F61437-017E-4EA0-947A-A21ACE7EB2F9Q35974293-5FCFD8C6-7F78-4129-8216-E0E21AD092C8Q35975387-14430644-5290-4EFB-BE67-BACDD8CB0EC3Q36005646-2E43154B-1BE7-4BC1-825C-33C66A4A59BDQ36107975-E58F4D07-EE94-4479-A816-2C3F9A96A250Q36174218-0F3F16E1-BCAB-4D90-8A33-81E0CBF1F659Q36186619-356C0628-A38B-4BEA-98F8-6D1191D91EBB
P2860
Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Combination of T-cell therapy ...... ulature and tumor eradication.
@en
Combination of T-cell therapy ...... ulature and tumor eradication.
@nl
type
label
Combination of T-cell therapy ...... ulature and tumor eradication.
@en
Combination of T-cell therapy ...... ulature and tumor eradication.
@nl
prefLabel
Combination of T-cell therapy ...... ulature and tumor eradication.
@en
Combination of T-cell therapy ...... ulature and tumor eradication.
@nl
P2093
P1433
P1476
Combination of T-cell therapy ...... culature and tumor eradication
@en
P2093
Bernd Arnold
Eduard Ryschich
Ernst Klar
Günter J Hämmerling
Ruth Ganss
P304
P407
P577
2002-03-01T00:00:00Z